Okay, let's tackle this question about mast cells and hypersensitivity reactions. First, I need to recall the different types of hypersensitivity reactions. There are four main types: I, II, III, and IV. Type I is immediate, like allergies. Type II is antibody-mediated, Type III is immune complex, and Type IV is delayed, cell-mediated.

The question is asking which type involves mast cells. From what I remember, mast cells are key players in Type I hypersensitivity. They release histamine and other mediators when IgE antibodies bind to their Fc receptors. So when an allergen is encountered, IgE cross-links the mast cell receptors, causing degranulation. That leads to symptoms like hives, anaphylaxis, etc.

Now, looking at the options, even though they aren't listed here, the correct answer should be Type I. Let me think about the other types. Type II involves antibodies (IgG or IgM) attacking cell surfaces, like in hemolytic anemia. Type III is about immune complexes causing inflammation, like in lupus. Type IV is T-cell mediated, such as contact dermatitis. None of these involve mast cells directly.

Wait, could there be any exceptions? I don't think so. Mast cells are specifically tied to IgE and immediate reactions. The clinical pearl here is to remember that mast cell degranulation is the hallmark of Type I, and the mediators they release are responsible for the acute symptoms. So the answer must be Type I hypersensitivity.

**Core Concept**
Mast cells are central to **Type I hypersensitivity reactions**, characterized by IgE-mediated immediate immune responses. These reactions involve cross-linking of IgE antibodies bound to mast cell FcεRI receptors, triggering degranulation and release of inflammatory mediators like histamine, leukotrienes, and cytokines. This mechanism underlies allergic conditions such as anaphylaxis, asthma, and urticaria.

**Why the Correct Answer is Right**
**Type I hypersensitivity** involves rapid mast cell activation via allergen-specific IgE. When an allergen bridges IgE molecules on mast cell surfaces, it induces degranulation. Released histamine increases vascular permeability and smooth muscle contraction, while late-phase reactions involve cytokines like IL-4 and IL-13. This pathway is distinct from other hypersensitivity types (e.g., Type IV, which is T-cell mediated).

**Why Each Wrong Option is Incorrect**
**Option A (Type II):** Involves IgG/IgM antibodies targeting cell surface antigens (e.g., Goodpasture’s disease), not mast cells.
**Option B (Type III):** Mediated by immune complex deposition (e.g., lupus nephritis), unrelated to mast cell degranulation.
**Option D (Type IV):** Cell-mediated via Th1/Th17 cells (e.g., contact dermatitis), lacking IgE or mast cell involvement.

**Clinical Pearl / High-Yield Fact**
Remember **“IgE equals mast cell degranulation”** for Type I reactions. A classic exam trap is confusing Type I with Type IV—note that Type I is IgE-mediated and immediate, while Type IV is delayed and T-cell driven. Always associate histamine release with mast cells in allergy scenarios.

**Correct Answer: B.

✓ Correct Answer: A. Immediate